Insiders · UNCY

UNCY insider transactions

Unicycive Therapeutics Inc. (UNCY) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for UNCY

• 18d
  SEC Form 4 filed by Director Kenkare-Mitra Sara

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 18d
  SEC Form 4 filed by CEO Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 19d
  SEC Form 4 filed by EVP, Corporate Strategy Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 19d
  SEC Form 4 filed by CFO Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 19d
  SEC Form 4 filed by EVP, Pharmaceuticals and BD Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 21d
  SEC Form 4 filed by Director Laumas Sandeep

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 286d
  Director Aggarwal Gaurav converted options into 652,900 shares (SEC Form 4)

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 313d
  SEC Form 4 filed by Director Kenkare-Mitra Sara

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 313d
  SEC Form 4 filed by EVP of Corporate Strategy Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 313d
  SEC Form 4 filed by CEO Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 313d
  SEC Form 4 filed by Director Laumas Sandeep

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 313d
  SEC Form 4 filed by EVP, Pharmaceuticals and BD Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 313d
  SEC Form 4 filed by Director Aggarwal Gaurav

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 313d
  SEC Form 4 filed by Chief Financial Officer Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 474d
  Director Aggarwal Gaurav converted options into 1,400,000 shares (SEC Form 4)

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 606d
  Director Aggarwal Gaurav converted options into 5,500,000 shares (SEC Form 4)

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 663d
  SEC Form 4 filed by Chief Financial Officer Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 663d
  SEC Form 4 filed by EVP, Pharmaceuticals and BD Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 663d
  SEC Form 4 filed by CEO Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 663d
  SEC Form 4 filed by EVP of Corporate Strategy Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 782d
  SEC Form 4 filed by Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 782d
  SEC Form 4 filed by Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 782d
  SEC Form 4 filed by Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 782d
  SEC Form 4 filed by Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1005d
  SEC Form 4 filed by Laumas Sandeep

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1005d
  SEC Form 4 filed by Kenkare-Mitra Sara

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1005d
  SEC Form 4 filed by Ryan John L

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1005d
  SEC Form 4 filed by Aggarwal Gaurav

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1005d
  SEC Form 3 filed by new insider Kenkare-Mitra Sara

  3 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1013d
  SEC Form 4 filed by Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1013d
  SEC Form 4 filed by Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1013d
  SEC Form 4 filed by Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1013d
  SEC Form 4 filed by Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1061d
  SEC Form 4 filed by Aggarwal Gaurav

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1061d
  SEC Form 4 filed by Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1061d
  SEC Form 4 filed by Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1061d
  SEC Form 4 filed by Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1147d
  SEC Form 4 filed by Schiller Brigitte (Amendment)

  4/A - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1187d
  SEC Form 4 filed by Aggarwal Gaurav

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1187d
  SEC Form 4 filed by Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1187d
  SEC Form 4 filed by Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1187d
  SEC Form 4 filed by Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1188d
  SEC Form 3 filed by new insider Aggarwal Gaurav

  3 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1293d
  SEC Form 4 filed by Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1293d
  SEC Form 4 filed by Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1293d
  SEC Form 4 filed by Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1293d
  SEC Form 4 filed by Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1295d
  SEC Form 3: New insider Jermasek Douglas claimed ownership of 70,400 shares

  3 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1378d
  SEC Form 4: Schiller Brigitte converted options into 26,738 shares

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1483d
  SEC Form 4: Schiller Brigitte bought $12,375 worth of shares (15,000 units at $0.82)

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)